Dr. Petter Bjornstad Named Senior Vice Chancellor and Executive Director of LSU’s Pennington Biomedical Research Center

Dr. Bjornstad is a nationally recognized physician-scientist and currently serves as Executive Director of the UW Medicine Diabetes Institute [PR.com]

Posted on: 7 November 2026 | 10:41 pm

Pennington Biomedical Researchers Develop New Animal Model Offering More Precise Way to Study Calorie-Burning Brown Fat

Animal model reduces unintended genetic activity in the brain and other tissues [PR.com]

Posted on: 7 November 2026 | 10:40 pm

New York Health Welcomes Family Medicine Physician, Dr. Raja Mehta

New York Health (NY Health) is proud to announce the addition of Dr. Raja Mehta, a board-certified family medicine physician focused on preventive medicine, chronic disease management, and comprehensive primary care. Beginning November 2, 2026, Dr. Raja Mehta will practice at NY Health’s office at 267 E Main Street, Smithtown, NY 11787. “We are pleased to welcome Dr. Mehta to New York Health,” said Dr. [PR.com]

Posted on: 3 November 2026 | 2:00 am

Microvascular Therapeutics to Present New Clinical and Preclinical Data on CardiSon™ and Solv™ at the 2026 Contrast Media Research Symposium

Presentations highlight superior echocardiographic performance of CardiSon and 70% reduction in myocardial infarct size with ultrasound-activated Solv in a preclinical model. [PR.com]

Posted on: 30 October 2026 | 5:00 am

Emerge Weight Loss Extends Compassionate GLP-1 Care to Adults Living with Obstructive Sleep Apnea

As landmark research shows tirzepatide can cut sleep apnea severity by roughly half, Emerge brings medically supervised, whole-person telehealth care to the millions of adults who wake up every morning still exhausted. [PR.com]

Posted on: 27 October 2026 | 8:45 am

Pennington Biomedical Researchers Examine Low Testosterone Screening Rates Among U.S. Army Personnel

Study published in JAMA estimates that about 1 in 4 active-duty male soldiers has a single morning testosterone measurement below a commonly used clinical threshold [PR.com]

Posted on: 17 October 2026 | 2:00 am

Pennington Biomedical Study Links Life-Course Clinical Obesity to Signs of Brain Health Changes in Midlife

Bogalusa Heart Study findings provide new evidence connecting cumulative clinical obesity with white matter changes in the brain [PR.com]

Posted on: 16 October 2026 | 2:00 am

Pennington Biomedical's “Be the Reason Kids Greaux Healthy” Connects Experts to Advance Childhood Obesity Care

Annual conference connects research, healthcare and community strategies to address childhood obesity [PR.com]

Posted on: 16 October 2026 | 2:00 am

Study from Pennington Biomedical Reveals How Warm Temperatures Influence Appetite and Weight Gain

Scientists identified neurons that connect warm temperatures with appetite and energy expenditure, providing new insight into how environment influences body weight. [PR.com]

Posted on: 9 October 2026 | 12:50 am

THROMBOLEX Announces Interim RAPID-PE Results

THROMBOLEX Announces Interim RAPID-PE Results Showing Favorable Safety and Reproducible Multicenter Results in Acute Pulmonary Embolism. Mechanically channeled thrombolysis procedure disrupts and dissolves thrombus in a single on-the-table session. [PR.com]

Posted on: 5 October 2026 | 6:47 am

Pennington Biomedical and Others Examine What Science Says About Ultraprocessed Foods and the Aging Brain

Dr. Owen Carmichael and an international team examine evidence linking diet, brain health and cognitive aging in the 2026 Annual Review of Nutrition. [PR.com]

Posted on: 4 October 2026 | 6:51 am

Pennington Biomedical and Collaborators Identify Brain Circuit Linked to Food Cravings During Pregnancy

Study in Nature Neuroscience provides new insight into how pregnancy alters brain circuits that influence food motivation. [PR.com]

Posted on: 4 October 2026 | 6:51 am

Pennington Biomedical Researchers Help Advance New Tool for Analyzing Continuous Glucose Monitoring Data

GVC-Calc provides researchers with a scalable and transparent approach to analyzing data from continuous glucose monitors. [PR.com]

Posted on: 4 October 2026 | 6:51 am

Pennington Biomedical Researchers Offer New Perspective on How Protein Restriction May Promote Healthy Aging and Longevity

Published in Cell Metabolism, the paper suggests protein restriction triggers a coordinated whole-body response that may help explain its effects on healthy aging. [PR.com]

Posted on: 4 October 2026 | 6:51 am

Microvascular Therapeutics to Present Phase II CardiSon™ Data at 40th International Bubble Conference in Chicago

Next-generation ultrasound enhancing agent demonstrated improved left ventricular opacification and significantly reduced acoustic shadowing [PR.com]

Posted on: 2 October 2026 | 2:00 am

New York Health Welcomes Nephrologist, Dr. Oscar Andres Rodriguez Ayala

New York Health (NY Health) is proud to announce the addition of nephrologist, Dr. Oscar Andres Rodriguez Ayala. Beginning October 1, 2026, Dr. Rodriguez Ayala will practice at NY Health’s office at 5316 Nesconset Highway, Port Jefferson Station, NY 11776. “We are pleased to welcome Dr. Rodriguez Ayala to New York Health,” said Dr. Rohit Reejsinghani, Chief Medical Officer of NY Health. “His [PR.com]

Posted on: 2 October 2026 | 2:00 am

Canada Peptide Research Co. Expands Batch-Level Documentation and Research Education Resources

Canada Peptide Research is a Vancouver-based supplier serving the Canadian research market. The company focuses on research materials, batch-level documentation, third-party analytical testing where available, educational resources and Canadian fulfillment. [PR.com]

Posted on: 1 October 2026 | 11:22 am

ALS TDI to Convene ALS Research, Industry, and Community Leaders at 2026 Summit and White Coat Affair Gala

This October, two Boston events will bring people together to share research updates, build connections, and accelerate progress for people with ALS. [PR.com]

Posted on: 23 September 2026 | 7:40 am

SignaBlok Awarded NIH NIDDK Grant to Develop Novel TREM-1 Antagonist Drug for Inflammatory Bowel Disease

SignaBlok, Inc. has been awarded a Phase I SBIR grant from the NIH NIDDK to advance the development of a novel mechanism-based therapy for inflammatory bowel disease (IBD). The award supports SignaBlok's differentiated approach to targeting TREM-1 in IBD. [PR.com]

Posted on: 18 September 2026 | 2:00 am

Pennington Biomedical Researcher Dr. Emily Flanagan Launching Study on Infant Energy Balance and Early-Life Growth

First-of-its-kind study examining how energy intake and expenditure influence infant growth and future obesity risk. [PR.com]

Posted on: 5 September 2026 | 2:00 am

Pennington Biomedical Researchers Find Peroxisomes Help Protect Insulin and Maintain Beta Cell Health

Study reveals impaired peroxisomal function can increase insulin secretion while promoting insulin oxidation and disrupting pancreatic beta cell maturity. [PR.com]

Posted on: 3 September 2026 | 3:11 pm

Beyond the Scale: Emerge Weight Loss Expands GLP-1 Telehealth Care to Support Women Living With PCOS and Endometriosis

As emerging research illuminates tirzepatide's metabolic and anti-inflammatory effects, Emerge extends compassionate, medically supervised weight loss care from board-certified providers to women whose health needs reach far beyond a number on the scale. [PR.com]

Posted on: 2 September 2026 | 8:04 am

Helix BioMedix Completes $2 Million Private Placement to Advance Xeroderma Pigmentosum Development Program

Financing strengthens balance sheet and accelerates advancement of proprietary DNA repair technology targeting UV-induced DNA damage. [PR.com]

Posted on: 29 August 2026 | 2:00 am

Pennington Biomedical’s 2026 Childhood Obesity Conference: “Be the Reason Kids Greaux Healthy” to be Held Sept. 24

Event brings together healthcare professionals, researchers, educators and community leaders to explore strategies for preventing and treating childhood obesity. [PR.com]

Posted on: 27 August 2026 | 2:00 am

Pennington Biomedical's Dr. Steven Heymsfield Co-Authors Editorial Highlighting the Unanticipated Benefits of GLP-1 Medications

Dr. Steven Heymsfield and Dr. Adam Gilden’s Obesity journal editorial highlights emerging benefits and questions surrounding this rapidly expanding class of medications [PR.com]

Posted on: 26 August 2026 | 10:29 am